PLUS: Google's human trials of its AI-designed drugs
Great one, as always. Feels a little cleaner with Substack. Not a good or bad thing, just different. I might lean toward Beehiiv because it has more personality but I'll read either way you send it.
Thank you, Shawn. Really appreciated. Good to know either works for you, though.
Amazing
Thank you, Andres. Appreciate it.
Great one, as always. Feels a little cleaner with Substack. Not a good or bad thing, just different. I might lean toward Beehiiv because it has more personality but I'll read either way you send it.
Thank you, Shawn. Really appreciated. Good to know either works for you, though.
Amazing
Thank you, Andres. Appreciate it.